AASLD: New HCV Drugs Draw Attention (with video)
SAN FRANCISCO (MedPage Today) — Two new agents that act directly on the hepatitis C virus already approved and and details are being reported here at the annual meeting of the American Association for the Study of Liver Diseases, and in this exclusive InFocus video, on many more now in the pipeline.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com